Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi and United Therapeutics could pay more than $5,000 for each violation.
from Section Page News - Modern Healthcare https://ift.tt/2W7QulD
Thursday, September 23, 2021
Six drugmakers face fines for 340B contract pharmacy violationsSix drugmakers face fines for 340B contract pharmacy violationsSix drugmakers face fines for 340B contract pharmacy violations
Six drugmakers face fines for 340B contract pharmacy violations
from Section Page News - Modern Healthcare https://ift.tt/2W7QulD
from Section Page News - Modern Healthcare https://ift.tt/2W7QulD
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment